The Will Erwin Headache Research Center - Cluster Headache Study (NCT02910323) | Clinical Trial Compass
RecruitingNot Applicable
The Will Erwin Headache Research Center - Cluster Headache Study
United States1,500 participantsStarted 2016-07-12
Plain-language summary
The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia is a prospective, multicenter, observational research network for subjects with Cluster Headache and/or Trigeminal Neuralgia.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of a trigeminal autonomic cephalalgia according to the International Headache Classification including episodic cluster headache, chronic cluster headache, episodic paroxysmal hemicrania, chronic paroxysmal hemicrania, episodic short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT), chronic SUNCT, episodic short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA), chronic SUNA, and hemicrania continua. OR Diagnosis of a trigeminal neuralgia according to the International Headache Classification, including classical trigeminal neuralgia and symptomatic trigeminal neuralgia.
* Able to provide HIPAA authorization to share prior medical records/imaging.
Exclusion Criteria:
* Life expectancy less than 1 year, co-existing disease or other characteristic that precludes appropriate diagnosis of a trigeminal autonomic cephalalgia or trigeminal neuralgia.
* Active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements
* Inability or unwillingness of subject or legal guardian/representative to give informed consent.
Inclusion Criteria for Healthy Volunteers:
* Inclusion criteria is willingness to consent and be of age 18 and older
What they're measuring
1
HIT-6 scale
Timeframe: Through study completion, an average of 5 years
2
Morningness-eveningness scale
Timeframe: Through study completion, an average of 5 years
3
GAD-7 scale
Timeframe: Through study completion, an average of 5 years
Trial details
NCT IDNCT02910323
SponsorThe University of Texas Health Science Center, Houston